Table of Contents
1 Market Overview
1.1 Dendritic Cell Cancer Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dendritic Cell Cancer Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 CreaVax
1.2.3 Sipuleucel-T (Provenge)
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Dendritic Cell Cancer Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pediatrics
1.3.3 Adults
1.4 Overview of Global Dendritic Cell Cancer Vaccine Market
1.4.1 Global Dendritic Cell Cancer Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Medigene
2.1.1 Medigene Details
2.1.2 Medigene Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Medigene SWOT Analysis
2.1.4 Medigene Product and Services
2.1.5 Medigene Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 DCPrime
2.2.1 DCPrime Details
2.2.2 DCPrime Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 DCPrime SWOT Analysis
2.2.4 DCPrime Product and Services
2.2.5 DCPrime Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Batavia Bioservices
2.3.1 Batavia Bioservices Details
2.3.2 Batavia Bioservices Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Batavia Bioservices SWOT Analysis
2.3.4 Batavia Bioservices Product and Services
2.3.5 Batavia Bioservices Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Activarti
2.4.1 Activarti Details
2.4.2 Activarti Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Activarti SWOT Analysis
2.4.4 Activarti Product and Services
2.4.5 Activarti Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 DanDrit Biotech
2.5.1 DanDrit Biotech Details
2.5.2 DanDrit Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 DanDrit Biotech SWOT Analysis
2.5.4 DanDrit Biotech Product and Services
2.5.5 DanDrit Biotech Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Argos Therapeutics
2.6.1 Argos Therapeutics Details
2.6.2 Argos Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Argos Therapeutics SWOT Analysis
2.6.4 Argos Therapeutics Product and Services
2.6.5 Argos Therapeutics Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Elios Therapeutics
2.7.1 Elios Therapeutics Details
2.7.2 Elios Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Elios Therapeutics SWOT Analysis
2.7.4 Elios Therapeutics Product and Services
2.7.5 Elios Therapeutics Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Creagene
2.8.1 Creagene Details
2.8.2 Creagene Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Creagene SWOT Analysis
2.8.4 Creagene Product and Services
2.8.5 Creagene Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bellicum Pharmaceuticals
2.9.1 Bellicum Pharmaceuticals Details
2.9.2 Bellicum Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bellicum Pharmaceuticals SWOT Analysis
2.9.4 Bellicum Pharmaceuticals Product and Services
2.9.5 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sanpower (Dendreon)
2.10.1 Sanpower (Dendreon) Details
2.10.2 Sanpower (Dendreon) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sanpower (Dendreon) SWOT Analysis
2.10.4 Sanpower (Dendreon) Product and Services
2.10.5 Sanpower (Dendreon) Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Glaxo Smith Kline
2.11.1 Glaxo Smith Kline Details
2.11.2 Glaxo Smith Kline Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Glaxo Smith Kline SWOT Analysis
2.11.4 Glaxo Smith Kline Product and Services
2.11.5 Glaxo Smith Kline Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Vaxil Bio
2.12.1 Vaxil Bio Details
2.12.2 Vaxil Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Vaxil Bio SWOT Analysis
2.12.4 Vaxil Bio Product and Services
2.12.5 Vaxil Bio Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Immunicum
2.13.1 Immunicum Details
2.13.2 Immunicum Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Immunicum SWOT Analysis
2.13.4 Immunicum Product and Services
2.13.5 Immunicum Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 ImmunoCellular
2.14.1 ImmunoCellular Details
2.14.2 ImmunoCellular Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 ImmunoCellular SWOT Analysis
2.14.4 ImmunoCellular Product and Services
2.14.5 ImmunoCellular Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Northwest Biotherapeutics
2.15.1 Northwest Biotherapeutics Details
2.15.2 Northwest Biotherapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Northwest Biotherapeutics SWOT Analysis
2.15.4 Northwest Biotherapeutics Product and Services
2.15.5 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Kiromic
2.16.1 Kiromic Details
2.16.2 Kiromic Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Kiromic SWOT Analysis
2.16.4 Kiromic Product and Services
2.16.5 Kiromic Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Medigene
2.17.1 Medigene Details
2.17.2 Medigene Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Medigene SWOT Analysis
2.17.4 Medigene Product and Services
2.17.5 Medigene Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Tella
2.18.1 Tella Details
2.18.2 Tella Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Tella SWOT Analysis
2.18.4 Tella Product and Services
2.18.5 Tella Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Merck
2.19.1 Merck Details
2.19.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Merck SWOT Analysis
2.19.4 Merck Product and Services
2.19.5 Merck Dendritic Cell Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Dendritic Cell Cancer Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Dendritic Cell Cancer Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Dendritic Cell Cancer Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Dendritic Cell Cancer Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Dendritic Cell Cancer Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Dendritic Cell Cancer Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Dendritic Cell Cancer Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Dendritic Cell Cancer Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Dendritic Cell Cancer Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Dendritic Cell Cancer Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Dendritic Cell Cancer Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Dendritic Cell Cancer Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Dendritic Cell Cancer Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
6.4 France Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Dendritic Cell Cancer Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Dendritic Cell Cancer Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Dendritic Cell Cancer Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
7.5 India Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Dendritic Cell Cancer Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Dendritic Cell Cancer Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Dendritic Cell Cancer Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Dendritic Cell Cancer Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Dendritic Cell Cancer Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Dendritic Cell Cancer Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Dendritic Cell Cancer Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Dendritic Cell Cancer Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Dendritic Cell Cancer Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Dendritic Cell Cancer Vaccine Price by Type (2015-2020)
11 Global Dendritic Cell Cancer Vaccine Market Segment by Application
11.1 Global Dendritic Cell Cancer Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Dendritic Cell Cancer Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Dendritic Cell Cancer Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Dendritic Cell Cancer Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Dendritic Cell Cancer Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Dendritic Cell Cancer Vaccine Market Forecast (2021-2025)
12.2.2 Europe Dendritic Cell Cancer Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Dendritic Cell Cancer Vaccine Market Forecast (2021-2025)
12.2.4 South America Dendritic Cell Cancer Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Dendritic Cell Cancer Vaccine Market Forecast (2021-2025)
12.3 Dendritic Cell Cancer Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Dendritic Cell Cancer Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Dendritic Cell Cancer Vaccine Market Share Forecast by Type (2021-2025)
12.4 Dendritic Cell Cancer Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Dendritic Cell Cancer Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Dendritic Cell Cancer Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
【掲載企業】
Medigene、DCPrime、Batavia Bioservices、Activarti、DanDrit Biotech、Argos Therapeutics、Elios Therapeutics、Creagene、Bellicum Pharmaceuticals、Sanpower (Dendreon)、Glaxo Smith Kline、Vaxil Bio、Immunicum、ImmunoCellular、Northwest Biotherapeutics、Kiromic、Medigene、Tella、Merck
【免責事項】
https://www.globalresearch.jp/disclaimer